Ticker
EOLSCompany Name
EVOLUS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Cash and Equivalents | Cash Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 61.74M | 0.97 | $ 63.75M |
3/31/2025 | $ 67.89M | 1.21 | $ 56.23M |
12/31/2024 | $ 86.95M | 1.38 | $ 62.96M |
9/30/2024 | $ 85.03M | 1.4 | $ 60.81M |
6/30/2024 | $ 93.67M | 1.73 | $ 54.12M |
3/31/2024 | $ 96.96M | 2.07 | $ 46.8M |
12/31/2023 | $ 62.84M | 1.3 | $ 48.29M |
9/30/2023 | $ 38.69M | 0.8 | $ 48.54M |
6/30/2023 | $ 41.7M | 1.01 | $ 41.35M |
3/31/2023 | $ 31.46M | 0.77 | $ 40.68M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for EVOLUS INC is calculated as follows: CashnEq [ $ 85.13M ] / LiabilitesC [ $ 12.71M ]
(=) Cash Ratio [ 6.7 ]
Minimum
Mar 31, 2021
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.13K |
---|---|
min | 0 |
max | 2.69 |
average | 0.62 |
median | 0.39 |
std | 0.63 |